JPMorgan Chase & Co’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63 | Sell |
33
-5,482
| -99% | -$10.5K | ﹤0.01% | 5992 |
|
|
2025
Q1 | $39.1K | Sell |
5,515
-9,807
| -64% | -$69.5K | ﹤0.01% | 5108 |
|
|
2024
Q4 | $337K | Buy |
15,322
+12,773
| +501% | +$281K | ﹤0.01% | 4327 |
|
|
2024
Q3 | $51.2K | Buy |
2,549
+74
| +3% | +$1.49K | ﹤0.01% | 4973 |
|
|
2024
Q2 | $43.1K | Buy |
2,475
+771
| +45% | +$13.4K | ﹤0.01% | 4949 |
|
|
2024
Q1 | $71.1K | Sell |
1,704
-956
| -36% | -$39.9K | ﹤0.01% | 4849 |
|
|
2023
Q4 | $66.9K | Hold |
2,660
| – | – | ﹤0.01% | 4920 |
|
|
2023
Q3 | $87K | Sell |
2,660
-522
| -16% | -$17.1K | ﹤0.01% | 4697 |
|
|
2023
Q2 | $185K | Sell |
3,182
-17,686
| -85% | -$1.03M | ﹤0.01% | 4312 |
|
|
2023
Q1 | $545K | Buy |
20,868
+16,881
| +423% | +$441K | ﹤0.01% | 3778 |
|
|
2022
Q4 | $119K | Buy |
+3,987
| New | +$119K | ﹤0.01% | 4433 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | – | – | 5972 |
|
|
2021
Q4 | $0 | Buy |
+7
| New | – | ﹤0.01% | 5939 |
|
|
2021
Q3 | – | Sell |
-1,578
| Closed | -$308K | – | 5775 |
|
|
2021
Q2 | $308K | Buy |
1,578
+44
| +3% | +$8.59K | ﹤0.01% | 4268 |
|
|
2021
Q1 | $396K | Buy |
1,534
+230
| +18% | +$59.4K | ﹤0.01% | 4169 |
|
|
2020
Q4 | $252K | Buy |
1,304
+1,016
| +353% | +$196K | ﹤0.01% | 4073 |
|
|
2020
Q3 | $58K | Sell |
288
-269
| -48% | -$54.2K | ﹤0.01% | 4249 |
|
|
2020
Q2 | $155K | Buy |
557
+430
| +339% | +$120K | ﹤0.01% | 3785 |
|
|
2020
Q1 | $38K | Sell |
127
-3
| -2% | -$898 | ﹤0.01% | 4212 |
|
|
2019
Q4 | $42K | Hold |
130
| – | – | ﹤0.01% | 4288 |
|
|
2019
Q3 | $49K | Buy |
130
+66
| +103% | +$24.9K | ﹤0.01% | 4264 |
|
|
2019
Q2 | $30K | Buy |
64
+57
| +814% | +$26.7K | ﹤0.01% | 4436 |
|
|
2019
Q1 | $4K | Sell |
7
-3
| -30% | -$1.71K | ﹤0.01% | 4726 |
|
|
2018
Q4 | $4K | Buy |
10
+3
| +43% | +$1.2K | ﹤0.01% | 4728 |
|
|
2018
Q3 | $2K | Sell |
7
-395
| -98% | -$113K | ﹤0.01% | 4763 |
|
|
2018
Q2 | $263K | Sell |
402
-973
| -71% | -$637K | ﹤0.01% | 3718 |
|
|
2018
Q1 | $5.66M | Buy |
1,375
+83
| +6% | +$342K | ﹤0.01% | 2132 |
|
|
2017
Q4 | $2.97M | Buy |
+1,292
| New | +$2.97M | ﹤0.01% | 2539 |
|